GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,560.00
+5.00 (0.11%)
Last updated: Aug 26, 2025
0.11%
Market Cap39.01B
Revenue (ttm)88.46B
Net Income (ttm)3.60B
Shares Out8.61M
EPS (ttm)417.89
PE Ratio10.84
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume51,094
Average Volume786,195
Open4,525.00
Previous Close4,555.00
Day's Range4,475.00 - 4,580.00
52-Week Range3,015.00 - 5,790.00
Beta0.44
RSI51.70
Earnings DateAug 14, 2025

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 41
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2024, GeneBioTech Co. ,Ltd's revenue was 82.96 billion, an increase of 4.38% compared to the previous year's 79.48 billion. Earnings were 2.87 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.